4D Molecular Therapeutics (FDMT) EBT (2020 - 2026)
4D Molecular Therapeutics' (FDMT) quarterly EBT came in at -$94.9 million in Q1 2026, down 91.98% year-on-year from -$1.2 billion in Q1 2025, and down 626.73% on a QoQ basis from $18.0 million in Q4 2025.
4D Molecular Therapeutics (FDMT) EBT (2020 - 2026) Analysis & Trends
4D Molecular Therapeutics (FDMT) has 7 years of EBT data on file, last reported at -$94.9 million in Q1 2026.
- On a quarterly basis, EBT fell 91.98% year-over-year to -$94.9 million in Q1 2026; TTM through Mar 2026 was -$252.7 million, a 13.1% decrease from a year earlier, with the FY2025 full-year figure at -$298.6 million, down 3.38% from the prior year.
- EBT for Q1 2026 stood at -$94.9 million, down from $18.0 million in the prior quarter.
- Over the last five years, EBT for FDMT reached as high as $18.0 million in Q4 2025 and fell as low as -$94.9 million in Q1 2026.
- Historically, EBT has averaged -$48.4 million across 5 years, with a median of -$47.3 million in 2022.
- Across the five-year window, EBT slumped 217.09% in 2022 and surged 135.65% in 2025, its largest moves.
- Year by year, EBT stood at -$30.3 million in 2022, then fell by 9.21% to -$33.1 million in 2023, then tumbled by 52.85% to -$50.6 million in 2024, then jumped by 135.65% to $18.0 million in 2025, then plunged by 626.73% to -$94.9 million in 2026.
- Per Business Quant data, the three most recent EBT figures were -$94.9 million in Q1 2026, $18.0 million in Q4 2025, and -$85.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -15.31 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 259.22 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 438.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -453.82 Mn |
| 10 | 4D Molecular Therapeutics | 691.54 Mn | 300.64 Mn | - | -94.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -94.91 Mn |
| Dec 31, 2025 | 18.02 Mn |
| Sep 30, 2025 | -85.88 Mn |
| Jun 30, 2025 | -89.89 Mn |
| Mar 31, 2025 | -49.44 Mn |
| Dec 31, 2024 | -50.55 Mn |
| Sep 30, 2024 | -77.95 Mn |
| Jun 30, 2024 | -45.45 Mn |
| Mar 31, 2024 | -39.06 Mn |
| Dec 31, 2023 | -33.07 Mn |
| Sep 30, 2023 | -29.08 Mn |
| Jun 30, 2023 | -51.28 Mn |
| Mar 31, 2023 | -49.29 Mn |
| Dec 31, 2022 | -30.28 Mn |
| Sep 30, 2022 | -47.32 Mn |
| Jun 30, 2022 | -34.23 Mn |
| Mar 31, 2022 | -33.13 Mn |
| Dec 31, 2021 | -26.28 Mn |
| Sep 30, 2021 | -47.53 Mn |
| Jun 30, 2021 | -10.79 Mn |